MIAMI, May 26, 2016 -- Physician-scientists and researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine will present a selection of their latest cancer care and research at this year's American Society of Clinical Oncology (ASCO) Annual Meeting, June 3-7, at McCormick Place in Chicago, Ill.
In addition, Sylvester sarcoma expert Jonathan C. Trent, M.D., Ph.D., was named a member of the Cancer Education Committee on the Sarcoma Track, beginning on June 6.
Reporters interested in interviewing Sylvester researchers on-site at the conference should contact Patrick Bartosch at (201) 469-6408 or firstname.lastname@example.org.
Highlights of research presented by Sylvester researchers include:
Sunday, June 5
Immunotherapy in Sarcomas: Where Do We Go From Here?
Breelyn A. Wilky, M.D.; 10:36-10:48 a.m.; S406
Monday, June 6
Why Are Myelodysplastic Syndromes So Difficult to Cure?
Novel Concepts in Biology and Molecular Characterization of Myelodysplastic Syndromes
Stephen D. Nimer, M.D.; 9:45-10:05 a.m.; S406
Monday, June 6
Jonathan C. Trent, M.D., Ph.D.; 3-4:15 p.m.; S406
Join the conversation about this year's ASCO Annual Meeting by using the hashtag #ASCO16 on Facebook, Twitter, and Instagram.
About Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center, part of UHealth - the University of Miami Health System and the University of Miami Miller School of Medicine, is among the nation's leading cancer centers and South Florida's only Cancer Center of Excellence. A 2015 study by Memorial Sloan Kettering Cancer Center, published in The Journal of the American Medical Association, showed that cancer patients treated at Sylvester have a 10 percent higher chance of survival than those treated at nearly any other cancer center in the nation. With the combined strength of more than 120 cancer researchers and 130 cancer specialists, Sylvester discovers, develops and delivers more targeted therapies, providing the next generation of cancer clinical care - precision cancer medicine - to each patient. Our comprehensive diagnostics, coupled with teams of scientific and clinical experts who specialize in just one type of cancer, enable us to better understand each patient's individual cancer and develop treatments that target the cells and genes driving the cancer's growth and survival, leading to better outcomes. At Sylvester, patients have access to more treatment options and more cancer clinical trials than most hospitals in the southeastern United States. To better serve current and future patients, Sylvester has a network of conveniently located outpatient treatment facilities in Miami, Kendall, Hollywood, Plantation, Deerfield Beach and Coral Springs, with plans to open in Coral Gables in 2016. For more information, visit sylvester.org.